1 12

Cited 0 times in

Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis

Authors
Kim, TH; Kim, YB; Cheong, JY; Cho, SW; Kim, SS
Citation
Soonchunhyang medical science, 24(1):81-84, 2018
Journal Title
Soonchunhyang medical science
ISSN
2233-42892233-4297
Abstract
Non-alcoholic fatty liver disease has been observed in over 30% of patients who have received tamoxifen therapy. However, tamoxifen-induced non-alcoholic steatohepatitis (NASH) cirrhosis has never been reported in Korea. A 41-year-old woman was diagnosed with invasive ductal carcinoma in the left breast. She had well-controlled type 2 diabetes mellitus, hypertension, and chronic hepatitis B. Ultrasonography showed mild fatty liver. Chronic hepatitis B had been treated with clevudine one month before the diagnosis of breast cancer. The patient was diagnosed with NASH cirrhosis 39 months after tamoxifen treatment. Careful observation for the development of NASH cirrhosis is warranted during tamoxifen therapy.
Keywords
Breast neoplasmsChronic hepatitis BNon-alcoholic fatty liver diseaseLiver cirrhosisTamoxifen
DOI
10.15746/sms.18.014
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Pathology
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
AJOU Authors
김, 영배정, 재연조, 성원김, 순선
Files in This Item:
Tamoxifen-Induced Non-alcoholic Steatohepatitis Cirrhosis.pdfDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse